Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Helen Lucraft.

Newcastle AuthorsTitleYearFull text
Dr Helen Lucraft
Risk of Premature Menopause After Treatment for Hodgkin's Lymphoma2014
Dr Helen Lucraft
Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors2013
Dr Christopher Bacon
Sarah Wilkinson
Dr Gavin Spickett
Dr Helen Lucraft
Professor Graham Jackson
et al.
Epstein-Barr virus-independent diffuse large B-cell lymphoma in DNA ligase 4 deficiency2013
Dr Helen Lucraft
Recommendations for the Use of Radiotherapy in Nodal Lymphoma2013
Dr Helen Lucraft
The Management of Children with Lymphomas2013
Dr Helen Lucraft
Breast Cancer Risk After Supradiaphragmatic Radiotherapy for Hodgkin's Lymphoma in England and Wales: A National Cohort Study2012
Professor Stephen Proctor
Dr Jennifer Wilkinson
Gillian Watson
Dr Helen Lucraft
Dr Tryfonia Mainou-Fowler
et al.
Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study2012
Professor Stephen Proctor
Dr Jennifer Wilkinson
Dr Helen Lucraft
Dr Richard McNally
Dr Tryfonia Mainou-Fowler
et al.
Comparative clinical responses of three chemotherapy schedules (VEPEMB, ABVD, CLVPP) in 175 Hodgkin Lymphoma patients over 60ys evaluated as part of the Shield (Hodgkin elderly) Study2011
Professor Stephen Proctor
Dr Anne Lennard
Professor Graham Jackson
Dr Jennifer Wilkinson
Dr Michal Sieniawski
et al.
The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control2010
Dr Helen Lucraft
Professor David Ellison
Impact of radiotherapy parameters on outcome for patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study2009
Dr Michal Sieniawski
Dr Jennifer Wilkinson
Dr Anne Lennard
Dr Helen Lucraft
Dr Tryfonia Mainou-Fowler
et al.
Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group.2008
Professor Stephen Proctor
Dr Jennifer Wilkinson
Dr Tryfonia Mainou-Fowler
Dr Michal Sieniawski
Dr Katrina Wood
et al.
SHIELD - Study of Hodgkin lymphoma in the elderly/lymphoma data base: Progress report2008
Dr Michal Sieniawski
Dr Tryfonia Mainou-Fowler
Dr Jennifer Wilkinson
Dr John Davison
Professor Graham Jackson
et al.
The effect of Diffuse Large B-Cell Lymphoma (DLBCL) treatment regimens on survival: a prospective cohort study [Poster]2008
Dr Helen Lucraft
Craniospinal irradiation using a forward planned segmented field technique2007
Dr Penelope Taylor
Dr Kevin Windebank
Dr Helen Lucraft
Dr Katrina Wood
Dr Brian Angus
et al.
Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescents2007
Dr Helen Lucraft
Patterns of outcome and prognostic factors in primary bone lymphoma (osteolymphoma): A survey of 499 cases by the international extranodal lymphoma study group2007
Dr Shyamal Wahie
Dr Helen Lucraft
Professor Peter Farr
Oropharyngeal mycosis fungoides2006
Dr Helen Lucraft
Professor Roderick Skinner
Secondary parotid mucoepidermoid carcinoma after TBI and chemotherapy in childhood AML2006
Dr Penelope Taylor
Dr Brian Angus
Professor Graham Jackson
Dr Helen Lucraft
Professor Stephen Proctor
et al.
The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trial2006
Professor Stephen Proctor
Dr Jennifer Wilkinson
Dr Helen Lucraft
Dr Penelope Taylor
Dr Katrina Wood
et al.
[abstract] International study of Hodgkin's lymphoma in the elderly2004
Professor David Ellison
Dr Helen Lucraft
Dr Richard Gilbertson
Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma2004
Dr Helen Lucraft
Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer2003
Dr Helen Lucraft
Primary cutaneous diffuse large B-cell lymphoma - Prognostic significance of clinicopathological subtypes2003
Professor David Ellison
Dr Helen Lucraft
Dr Richard Gilbertson
Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology United Kingdom Children's Cancer Study Group PNET-3 study2003
Professor Stephen Proctor
Professor Graham Jackson
Dr Anne Lennard
Dr Brian Angus
Dr Katrina Wood
et al.
Strategic approach to the management of Hodgkin's disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK)2003
Dr Helen Lucraft
Dr Timothy Cheetham
Successful radioiodine treatment in a 3 year old child with Graves' disease following antithyroid medication induced neutropenia2003
Dr Helen Lucraft
Association of soft tissue sarcomas other than neurofibrosarcoma with neurofibromatosis2002
Dr Helen Lucraft
Primary cutaneous follicular lymphoma - A clinicopathologic and molecular study of 16 cases in support of a distinct entity2002
Dr Helen Lucraft
Dr Richard Gilbertson
Results of the SIOP/UKCCSG PNET-3 randomised study of pre-radiotherapy chemotherapy compared with radiotherapy alone in M0/M1 medulloblastoma2002
Dr Edmund Ong
Dr Helen Lucraft
An aggressive intrasinusoidal lymphoma presenting with marked systemic disturbance but normal imaging studies2000
Dr Ujjal Mallick
George Proud
Nigel Jones
Dr Helen Lucraft
Dr John Fenwick
et al.
Lack of antigenicity of recombinant human thyrotropin after multiple injections in patients with differentiated thyroid cancer2000
Dr Ujjal Mallick
Dr John Fenwick
Dr Robert James
Dr Sarah Johnson
Professor Pat Kendall-Taylor
et al.
Northern cancer network guidelines for management of thyroid cancer2000
Dr Ujjal Mallick
Dr Helen Lucraft
George Proud
Dr Petros Perros
Dr John Fenwick
et al.
Optimizing the management of differentiated thyroid cancer.2000
Dr Helen Lucraft
Strategies to reduce deaths from breast cancer following mantle irradiation2000
Dr Amanda Potterton
Dr Andrew Chippindale
Dr John Wilsdon
Dr Helen Lucraft
Dr Peter Dawes
et al.
MRI appearances of the axilla in treated breast cancer1999
Dr Nicholas Wadd
Dr Helen Lucraft
Novel solutions to the problems encountered in electron irradiation to the surface of the head1999
Professor Simon Bailey
Professor Roderick Skinner
Dr Helen Lucraft
Emeritus Professor Robert Perry
Nicholas Todd
et al.
Pineal tumours in the north of England 1968-931996
Dr Penelope Taylor
Dr Helen Lucraft
Professor Stephen Proctor
Bone marrow examination in newly diagnosed Hodgkin's disease: Current practice in the United Kingdom1995
Professor Graham Jackson
Dr Anne Lennard
Dr Penelope Taylor
Dr Peter Carey
Dr Brian Angus
et al.
Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission1994
Dr Penelope Taylor
Professor Graham Jackson
Dr Anne Lennard
Dr Helen Lucraft
Professor Stephen Proctor
et al.
Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue1993
Professor Andrew Pearson
Dr Jennifer Kernahan
Dr Helen Lucraft
Anne Thompson
Emeritus Professor Alan Craft
et al.
Low dose continuous infusion doxorubicin in children and young adults1993
Dr Penelope Taylor
Dr Helen Lucraft
Professor Stephen Proctor
Patient education for self-referral and on-demand treatment for herpes zoster in lymphoma patients1993
Dr Anne Lennard
Professor Stephen Proctor
Dr Brian Angus
Dr Helen Lucraft
Lomustine, vindesine and bleomycin (LVB) used in the treatment of relapsed advanced Hodgkin's disease: A prospective study on behalf of the east of Scotland and Newcastle lymphoma group (ESNLG)1989